Targeted vezf1-null mutation impairs vascular structure formation during embryonic stem cell differentiation

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 30, Issue 7, 2010, Pages 1378-1388

  Zou, Zhongmin ^a,c   Ocaya, Pauline A ^b   Sun, Huiqin ^a   Kuhnert, Frank ^a,d   Stuhlmann, Heidi ^a,b,c  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

angiogenesis; biology; developmental; embryoid body differentiation; embryonic stem cells; endothelium; gene knockout; gene mutations; teratocarcinoma; vascular biology; Vezf1

Indexed keywords

RETINOL;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GENE; GENE FUNCTION; IMMUNOHISTOCHEMISTRY; KNOCKOUT GENE; MOUSE; NONHUMAN; NULL ALLELE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TERATOCARCINOMA; VEZF1 GENE;

ANIMALS; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; EMBRYONAL CARCINOMA STEM CELLS; EMBRYONIC STEM CELLS; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENOTYPE; HEMATOPOIETIC STEM CELLS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; MICE; MICE, NUDE; MUTATION; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PHENOTYPE; SIGNAL TRANSDUCTION; TERATOCARCINOMA; TIME FACTORS; VITAMIN A;

EID: 77953961942     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.109.200428     Document Type: Article

References (50)

1. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med. 2000;6:389-395.
2. Risau W. Mechanisms of angiogenesis. Nature. 1997;386:671-674.
3. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000;407:249-257.
4. Carmeliet P. Angiogenesis in life, disease and medicine. Nature. 2005; 438:932-936.
5. Jain RK. Molecular regulation of vessel maturation. Nat Med. 2003;9: 685-693.
6. Oettgen P. Transcriptional regulation of vascular development. Circ Res. 2001;89:380-388.
7. Minami T, Aird WC. Endothelial cell gene regulation. Trends Cardiovasc Med. 2005;15:174-184.
8. Dejana E, Taddei A, Randi AM. Foxs and Ets in the transcriptional regulation of endothelial cell differentiation and angiogenesis. Biochim Biophys Acta. 2007;1775:298-312.
9. Xiong J-W, Battaglino R, Leahy A, Stuhlmann H. Large-scale screening for developmental genes in ES cells and embryoid bodies using retroviral entrapment vectors. Dev Dyn. 1998;212:181-197.
10. Xiong J-W, Leahy A, Lee H-H, Stuhlmann H. Vezf1: a Zn finger transcription factor restricted to endothelial cells and their precursors. Dev Biol. 1999;206:123-141.
11. Kuhnert F, Stuhlmann H. Identifying early vascular genes through gene trapping in mouse embryonic stem cells. Curr Top Dev Biol. 2004;62: 261-281.
12. Kuhnert F, Stuhlmann H. Vezf1: A Transcriptional Regulator of the Endothelium. Cambridge, United Kingdom: Cambridge University Press; 2007.
13. Miyashita H, Kanemura M, Yamazaki T, Abe M, Sato Y. Vascular endothelial zinc finger 1 is involved in the regulation of angiogenesis: possible contribution of stathmin/OP18 as a downstream target gene. Arterioscler Thromb Vasc Biol. 2004;24:878-884.
14. Lebowitz PF, Prendergast GC. Functional interaction between RhoB and the transcription factor DB1. Cell Adhes Commun. 1998;6:277-287.
15. Aitsebaomo J, Kingsley-Kallesen ML, Wu Y, Quertermous T, Patterson C. Vezf1/DB1 is an endothelial cell-specific transcription factor that regulates expression of the endothelin-1 promoter. J Biol Chem. 2001; 276:39197-39205.
16. Aitsebaomo J, Wennerberg K, Der CJ, Zhang C, Kedar V, Moser M, Kingsley-Kallesen ML, Zeng GQ, Patterson C. p68RacGAP is a novel GTPase-activating protein that interacts with vascular endothelial zinc finger-1 and modulates endothelial cell capillary formation. J Biol Chem. 2004;279:17963-17972.
17. Kuhnert F, Campagnolo L, Xiong JW, Lemons D, Fitch MJ, Zou Z, Kiosses WB, Gardner H, Stuhlmann H. Dosage-dependent requirement for mouse Vezf1 in vascular system development. Dev Biol. 2005;283:140-156.
18. Wartenberg M, Gunther J, Hescheler J, Sauer H. The embryoid body as a novel in vitro assay system for antiangiogenic agents. Lab Invest. 1998;78:1301-1314.
19. Kearney JB, Bautch VL. In vitro differentiation of mouse ES cells: hematopoietic and vascular development. Methods Enzymol. 2003;365: 83-98.
20. Feraud O, Prandini MH, Vittet D. Vasculogenesis and angiogenesis from in vitro differentiation of mouse embryonic stem cells. Methods Enzymol. 2003;365:214-228.
21. Vittet D, Prandini MH, Berthier R, Schweitzer A, Martin-Sisteron H, Uzan G, Dejana E. Embryonic stem cells differentiate in vitro to endothelial cells through successive maturation steps. Blood. 1996;88:3424-13421
22. Kearney JB, Ambler CA, Monaco KA, Johnson N, Rapoport RG, Bautch VL. Vascular endothelial growth factor receptor Flt-1 negatively regulates developmental blood vessel formation by modulating endothelial cell division. Blood. 2002;99:2397-2407.
23. Kearney JB, Kappas NC, Ellerstrom C, DiPaola FW, Bautch VL. The VEGF receptor flt-1 (VEGFR-1) is a positive modulator of vascular sprout formation and branching morphogenesis. Blood. 2004;103:4527-4535.
24. Robertson EJ. Embryo-derived stem cell lines. In: Robertson EJ, ed. Teratocarcinomas and Embryonic Stem Cells: A Practical Approach. Oxford, United Kingdom: IRL Press; 1987.
25. Liersch R, Nay F, Lu L, Detmar M. Induction of lymphatic endothelial cell differentiation in embryoid bodies. Blood. 2006;107:1214-1216.
26. Kreuger J, Nilsson I, Kerjaschki D, Petrova T, Alitalo K, Claesson-Welsh L. Early lymph vessel development from embryonic stem cells. Arterioscler Thromb Vasc Biol. 2006;26:1073-1078.
27. Blomhoff R, Blomhoff HK. Overview of retinoid metabolism and function. J Neurobiol. 2006;66:606-630.
28. von Eynatten M, Humpert PM. Retinol-binding protein-4 in experimental and clinical metabolic disease. Expert Rev Mol Diagn. 2008;8:289-299.
29. Chang YC, Kao YH, Hu DN, Tsai LY, Wu WC. All-trans retinoic acid remodels extracellular matrix and suppresses laminin-enhanced contractility of cultured human retinal pigment epithelial cells. Exp Eye Res. 2009;88:900-909.
30. Hellemans K, Grinko I, Rombouts K, Schuppan D, Geerts A. All-trans and 9-cis retinoic acid alter rat hepatic stellate cell phenotype differentially. Gut. 1999;45:134-142.
31. Qin YH, Lei FY, Hu P, Pei J, Feng ZB, Pang YS. Effect of all-trans retinoic acid on renal expressions of matrix metalloproteinase-2, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rats with glomerulosclerosis. Pediatr Nephrol. 2009;24:1477-1486.
32. de The H, Vivanco-Ruiz MM, Tiollais P, Stunnenberg H, Dejean A. Identification of a retinoic acid responsive element in the retinoic acid receptor beta gene. Nature. 1990;343:177-180.
33. Sucov HM, Murakami KK, Evans RM. Characterization of an auto-regulated response element in the mouse retinoic acid receptor type beta gene. Proc Natl Acad Sci USA. 1990;87:5392-5396.
34. Feraud O, Cao Y, VittetD. Embryonic stem cell-derived embryoid bodies development in collagen gels recapitulates sprouting angiogenesis. Lab Invest. 2001;81:1669-1681.
35. Taylor KL, Henderson AM, Hughes CC. Notch activation during endothelial cell network formation in vitro targets the basic HLH transcription factor HESR-1 and downregulates VEGFR-2/KDR expression. Microvasc Res. 2002;64:372-383.
36. Robson P, Stein P, Zhou B, Schultz RM, Baldwin HS. Inner cell mass-specific expression of a cell adhesion molecule (PECAM-1/CD31) in the mouse blastocyst. Dev Biol. 2001;234:317-329.
37. Keller GM. In vitro differentiation of embryonic stem cells. Curr Opin Cell Biol. 1995;7:862-869.
38. Kennedy M, Firpo M, Choi K, Wall C, Robertson S, Kabrun N, Keller G. A common precursor for primitive erythropoiesis and definitive haema-topoiesis. Nature. 1997;386:488-493.
39. Leahy A, Xiong J-W, Kuhnert F, Stuhlmann H. Use of developmental marker genes to define temporal and spatial patterns of differentiation during embryoid body formation. J. Exp. Zool. 1999;284.
40. Choi K, Chung YS, Zhang WJ. Hematopoietic and endothelial development of mouse embryonic stem cells in culture. Methods Mol Med. 2005;105:359-368.
41. Gao F, Shi HY, Daughty C, Cella N, Zhang M. Maspin plays an essential role in early embryonic development. Development. 2004;131:1479-1489.
42. Madri JA. Extracellular matrix modulation of vascular cell behaviour. Transpl Immunol. 1997;5:179-183.
43. Paulsson M. Basement membrane proteins: structure, assembly, and cellular interactions. Crit Rev Biochem Mol Biol. 1992;27:93-127.
44. Poschl E, Schlotzer-Schrehardt U, Brachvogel B, Saito K, Ninomiya Y, Mayer U. Collagen IV is essential for basement membrane stability but dispensable for initiation of its assembly during early development. Development. 2004;131:1619-1628.
45. Marin MP, Esteban-Pretel G, Alonso R, Sado Y, Barber T, Renau-Piqueras J, Timoneda J. Vitamin A deficiency alters the structure and collagen IV composition of rat renal basement membranes. J Nutr. 2005; 135:695-701.
46. Duncan SA, Nagy A, Chan W. Murine gastrulation requires HNF-4 regulated gene expression in the visceral endoderm: tetraploid rescue of Hnf-4(\/\) embryos. Development. 1997;124:279-287.
47. Maeshima Y, Colorado PC, Torre A, Holthaus KA, Grunkemeyer JA, Ericksen MB, Hopfer H, Xiao Y, Stillman IE, Kalluri R. Distinct antitumor properties of a type IV collagen domain derived from basement membrane. J Biol Chem. 2000;275:21340-21348.
48. Sudhakar A, Sugimoto H, Yang C, Lively J, Zeisberg M, Kalluri R. Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins. Proc Natl Acad Sci USA. 2003;100:4766-4771.
49. He GA, Luo JX, Zhang TY, Hu ZS, Wang FY. The C-terminal domain of canstatin suppresses in vivo tumor growth associated with proliferation of endothelial cells. Biochem Biophys Res Commun. 2004;318:354-360.
50. Gowher H, Stuhlmann H, Felsenfeld G. Vezf1 regulates genomic DNA methylation through its effects on expression of DNA methyltransferase Dnmt3b. Genes Dev. 2008;22:2075-2084.